The scrip had closed at Rs 2609.4 in the previous session. The stock quoted a 52-week low of Rs 2232.0 and a high of Rs 3040.0. The company quoted a market-cap of Rs 44759.41 crore on the BSE.
On BSE, 8,321 shares have changed hands on the counter so far. At its prevailing price, the stock traded at 36.04 times its trailing 12-month EPS of Rs 73.39 per share and 6.92 times its book value. The return on equity (ROE) stood at Rs 21.24.
For the quarter ended 31-Dec-2020, Torrent Pharmaceuticals Ltd. reported consolidated sales of Rs 2003.0 crore, down 0.79 per cent from the same quarter a year ago. The company reported 18.33 per cent YoY growth in net profit at Rs 297.0 crore for the latest quarter.
The relative strength index (RSI) of the stock stood at Friday. The RSI oscillates between zero and 100. Traditionally, it is considered overbought condition when the RSI value is above 70 and oversold when it is below 30.
Analysts say the RSI indicator should not be seen in isolation, as it may not be sufficient to take a trading call, just the way a fundamental analyst cannot give a “buy” or “sell” recommendation using a single valuation ratio.
Business News Governmental News Finance News
Need Your Help Today. Your $1 can change life.